.

BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Chubb
Boehringer Ingelheim
Teva
UBS
Dow
Medtronic
Baxter
Johnson and Johnson
Merck

Generated: September 21, 2017

DrugPatentWatch Database Preview

Zafirlukast - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for zafirlukast and what is the scope of zafirlukast freedom to operate?

Zafirlukast
is the generic ingredient in two branded drugs marketed by Par Pharm Inc and Dr Reddys Labs Ltd, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are two drug master file entries for zafirlukast. Seven suppliers are listed for this compound.

Summary for Generic Name: zafirlukast

Tradenames:2
Patents:0
Applicants:2
NDAs:2
Drug Master File Entries: see list2
Suppliers / Packagers: see list7
Bulk Api Vendors: see list68
Clinical Trials: see list4
Patent Applications: see list5,389
Therapeutic Class:Respiratory Tract Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:zafirlukast at DailyMed

Pharmacology for Ingredient: zafirlukast

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-002Nov 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-001Sep 26, 1996ABRXYesYes► Subscribe► Subscribe► Subscribe
Par Pharm Inc
ACCOLATE
zafirlukast
TABLET;ORAL020547-003Sep 17, 1999ABRXYesNo► Subscribe► Subscribe► Subscribe
Dr Reddys Labs Ltd
ZAFIRLUKAST
zafirlukast
TABLET;ORAL090372-001Nov 18, 2010ABRXNoNo► Subscribe► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Expired Orange Book Patents for Generic Ingredient: zafirlukast

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

US Department of Justice
McKesson
UBS
Moodys
Queensland Health
Cerilliant
Merck
Deloitte
Dow
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot